Posts tagged “UNC-CH”
The North Carolina Chamber will unveil an economic development "Dashboard" created by RTI International on Dec. 3 as part of its Vision 2030 project. Those involved may want to look at new demographic data compiled at UNC which projects where most people in the state will be living in 2050. Are you ready for a Charlotte-Triad-Triangle megalopolis?
Plenty of tech and biotech companies have been founded at the University of North Carolina at Chapel Hill but the university has also proved to be a fertile breeding ground for entrepreneurship in public health. Read about four public health spinouts from UNC's Gillings School of Public Health.
When 100 of the top lung doctors in the U.S. gathered in Houston recently to learn about GlaxoSmithKline's new respiratory drug, one message rang loud and clear: Don't ignore the pneumonia risk. It's part of a new "Patient First" strategy from GSK.
The Certified Educational Chief Technology Officer (CeCTO) program finished its fourth cohort and welcomed 20 new CeCTOs and 11 Leaders of the 21st Century last week in Chapel Hill.
Two University of North Carolina scientists are among the winners in a GSKcompetition designed to find potential new drugs in places other than pharmaceutical company labs. Read about what this means for the scientists and for GSK.
Joseph DeSimone, whose nanotechnology research in University of North Carolina at Chapel Hill labs formed the basis for spinout Liquidia Technologies, will step down as director of UNC's Kenan Institute of Private Enterprise 18 months after taking the top position.
Cree reports revenues of $391 million and earnings of 39 cents per share, both figures topping Wall Street analysts' expectations by a considerable margin. However, investors expected higher numbers for the current quarter. Shares opened sharply lower Wednesday, and two analysts cut their ratings on the stock.
OxyBio shares close up 30% after trifecta: Acquires pharma firm, hires CEO, adds potential $600M drug
Wall Street likes this deal. Morrisville-based OxyBio says it is buying privately held Phyxius Pharma for some $4.8 million in stock and is naming the co-founder and CEO of that company as its chief executive officer. It's also acquiring the rights to a drug that could be worth $600 million a year.
The National Institutes of Health awards UNC-CH a five-year grant for programs, drug development and technology targeting the improvement of healthcare across North Carolina. RTI International and N.C. A&T will share in the contract. Duke, meanwhile, receives a $47 million grant.
In an effort to cut costs, reduce the number of re-admissions and improve quality of life for patients, the UNC Health Care system is going to utilize analytics from IBM.
UNC researchers are working on improving how an antidote can be administered after a chemical attack. Nanotechnology could hold the key.
UNC is leading four other institutions in conducting cybersecurity in cloud computing. Read more about the federally funded research project.
RTI International is joining with the University of North Carolina at Chapel Hill and the National Institutes of Health in a research study sequencing the entire genome of 400 infants to find a way to improve early detection of genetic disorders.
The organizers of the North Carolina Next Generation Network project are wading through a larger than expected response from a variety of partnerships and firms that want to help build an ultra-high speed Internet project across the Triangle and Triad. The NCNGN project manager says the timeline for picking the builders is "fluid" but backers "hope the service will begin by the fourth quarter 2014." The full story is available to WRALTechWire Insiders
Nanotechnologies from UNC and MIT are combined to make nanoparticles in a way that could produce more effective medicines. And an NCSU graduate now working at MIT plays a key role. See what they did.